HHS Issues Advance Notice of Proposed Rulemaking on HIPAA and Firearm Background Check Reporting

The U.S. Department of Health and Human Services (HHS) issued on April 19 an advance notice of proposed rulemaking (ANPRM) regarding HIPAA and the National Instant Criminal Background Check System (NICS).  This action is based on one of the executive actions in President Obama’s plan to reduce gun violence, which was released in January 2013.

As we previously reported, one of the 23 executive actions in the President’s gun plan is to address unnecessary legal barriers under HIPAA that may prevent States from reporting information to the NICS.  The NICS is the federal government’s background check system for the sale or transfer of firearms by licensed dealers. 

Under federal law, certain persons are disqualified from possessing or receiving firearms, including individuals who have been:

  • Involuntarily committed to a mental institution;
  • Found incompetent to stand trial or not guilty by reason of insanity;
  • Otherwise determined, through a formal adjudication process, to have a severe mental condition that results in the individual’s presenting a danger to themselves or others or being incapable of managing their own affairs.

This is known as the “mental health prohibitor.” 

Continue Reading

HITECH Update #12: HHS Modifies HIPAA Enforcement Provisions

This post is part of our series on key aspects of the final HITECH omnibus rule published by the U.S. Department of Health and Human Services (HHS) in the Federal Register on January 25, 2013. Previous posts are available here. The regulations are effective March 26, 2013, but covered entities and business associates have until September 23, 2013, to comply with most new requirements.

The final HITECH omnibus rule adopts a number of modifications to Subparts C and D of Part 160 (HIPAA Enforcement Rule) to implement Section 13410 of the HITECH Act. Most significantly, the rule includes modifications to implement Section 13410(a) of the HITECH Act, which requires HHS to formally investigate a complaint if a preliminary investigation indicates a possible violation due to willful neglect, and to impose a civil money penalty for a violation due to willful neglect.

Continue Reading

HITECH UPDATE #11: New Restrictions on "Sale" of Personal Health Information

This post is part of our series on key aspects of the final HITECH omnibus rule published by the U.S. Department of Health and Human Services (HHS) in the Federal Register on January 25, 2013. Previous posts are available here. The regulations are effective March 26, 2013, but covered entities and business associates have until September 23, 2013, to comply with most new requirements.

The final rule implements Section 13405(d) of the HITECH Act, which generally prohibits a covered entity or a business associate from engaging in a “sale” of an individual’s PHI without authorization. 

Definition of Sale of PHI.  In response to requests from commenters, HHS amended its proposed rule to provide a definition of “sale of PHI.”  Section 164.502(a)(5)(ii)(B)(1) defines “sale of PHI” to mean a disclosure of PHI when the covered entity or business associate “directly or indirectly receives remuneration from or on behalf of the recipient of the PHI in exchange for the PHI.”  HHS expressly refused to limit this definition to instances where there is a transfer of ownership of PHI.  Furthermore, HHS included a broad interpretation of “remuneration.”  In contrast to the marketing provision where remuneration must be financial, HHS will consider nonfinancial benefits received in exchange for PHI as falling within the scope of the rule. 

However, payments a covered entity may receive in the form of grants, contracts, or other arrangements to perform programs or activities using PHI (i.e., a research study) will not be considered sale of PHI because “any provision of PHI to the payer is a byproduct of the service being provided.”  Rather, a sale of PHI occurs when the covered entity or business associate is being compensated “primarily” for supplying PHI.

Continue Reading

HITECH Update #10: HHS Releases First Sample Business Associate Agreement Provisions Since HITECH Act, Omnibus Rule

This post is part of our series on key aspects of the final HITECH omnibus rule published by the U.S. Department of Health and Human Services (HHS) in the Federal Register on January 25, 2013. Previous posts are available here. The regulations are effective March 26, 2013, but covered entities and business associates have until September 23, 2013, to comply with most new requirements.

The Department of Health and Human Services (“HHS”) recently published sample business associate agreement provisions that reflect new requirements in the final HITECH omnibus rule.  The sample provisions are available here.  As we previously wrote, the omnibus rule requires covered entities and business associates to add several new provisions to their business associate contracts.  In order to comply with these new requirements, covered entities and business associates should review existing agreements and ensure that future agreements account for the new requirements.

HITECH Update #9: Omnibus Rule Revises Individual Rights to Request Restrictions, Access to Protected Health Information

This post is part of our series on key aspects of the final HITECH omnibus rule published by the U.S. Department of Health and Human Services (HHS) in the Federal Register on January 25, 2013. Previous posts are available here. The regulations are effective March 26, 2013, but covered entities and business associates have until September 23, 2013, to comply with most new requirements.

The final HITECH omnibus rule implements provisions in the HITECH Act pertaining to two individual rights: an individual’s right to request a restriction on the disclosure of his or her protected health information (“PHI”) and an individual’s right to access his or her PHI. 

Right to Restrict Uses and Disclosures of PHI

The current Privacy Rule grants individuals the right to request restrictions on the use or disclosure of their PHI, but covered entities are not required to agree to such restrictions.  The HITECH Act strengthens the right to request restrictions on disclosures by requiring covered entities to accept a restriction on disclosing PHI to a health plan where the disclosure is for payment or health care operations purposes and the PHI “pertains solely to a health care item or service for which the health care provider involved as been paid out of pocket.”  The omnibus rule amends the Privacy Rule to account for this provision.  Under this new requirement, if a patient pays her physician in full for a specific blood test and requests that the physician not disclose PHI that pertains solely to that blood test to the health plan, the physician must agree to this restriction unless the disclosure is otherwise required by law.  In these circumstances, the health care provider also may not disclose the relevant PHI to a business associate of the health plan.  The restriction applies only where the service or item has been paid in full out of pocket; it does not apply to follow-up visits if they are not paid for in full out of pocket.

Continue Reading

HITECH Update #8: New Requirements for HIPAA Notices of Privacy Practices

This post is part of our series on key aspects of the final HITECH omnibus rule published by the U.S. Department of Health and Human Services (HHS) in the Federal Register on January 25, 2013. Previous posts are available here. The regulations are effective March 26, 2013, but covered entities and business associates have until September 23, 2013, to comply with most new requirements.

The final HITECH omnibus rule requires covered entities to add several new provisions to the Notice of Privacy Practices (“NPP”) that they distribute to patients and beneficiaries.  Generally, an NPP describes how the covered entity may use and disclose protected health information (“PHI”), an individual’s rights with respect to PHI (e.g., the right to access PHI and request restrictions on uses and disclosures), and the covered entity’s legal duties with respect to PHI (e.g., the duty to abide by the terms of the NPP).

Continue Reading

HITECH Update # 7: New HIPAA Requirements for Business Associates and Their Subcontractors

This post is part of our series on key aspects of the final HITECH omnibus rule published by the U.S. Department of Health and Human Services (HHS) in the Federal Register on January 25, 2013. Previous posts are available here. The regulations are effective March 26, 2013, but covered entities and business associates have until September 23, 2013, to comply with most new requirements.

The final HITECH omnibus rule includes a number of changes that will significantly affect business associates.  Business associates are now directly subject to various aspects of the HIPAA Privacy, Security, and Breach Notification Rules.  Furthermore, liability now extends much further down the chain, as the new rule also applies these requirements to subcontractors of business associates.

We discuss these and other changes affecting business associates, and their subcontractors, below.

Continue Reading

HITECH Update # 6: New Requirements for Business Associate Agreements

This post is part of our series on key aspects of the final HITECH omnibus rule issued by the U.S. Department of Health and Human Services (HHS) on January 17, 2013 (available here), and scheduled to be published in the Federal Register on January 25. Previous posts are available here. The regulations are effective March 26, 2013, but covered entities and business associates have until September 23, 2013, to comply with most new requirements.

The final rule addresses several changes to business associate agreements as a result of the new obligations imposed upon business associates by HITECH. 

 

Continue Reading

HITECH Update #5: HHS Tightens HIPAA Marketing Requirements

This post is part of our series on key aspects of the final HITECH omnibus rule issued by the U.S. Department of Health and Human Services (HHS) on January 17, 2013 (available here), and scheduled to be published in the Federal Register on January 25.  Previous posts are available here.  The regulations are effective March 26, 2013, but covered entities and business associates have until September 23, 2013, to comply with most new requirements. 

The final HITECH omnibus rule significantly tightens the HIPAA marketing restrictions.  As described below, HHS has modified the proposed approach to require authorization for almost all treatment and health care operations communications where the covered entity receives, from a third party, financial remuneration for making the communication.  This change will have major implications for the design of medical messaging programs.

Background.  The HIPAA Privacy Rule generally requires that a covered entity obtain prior written authorization from an individual before using that individual’s protected health information for marketing purposes.  Prior to the HITECH Act, certain communications, including those related to treatment and care coordination, were excluded from the definition of marketing.  But under the HITECH Act, if a covered entity or business associate receives direct or indirect payment in exchange for making certain communications (including those related to treatment and care coordination), the covered entity generally must obtain prior authorization--unless the communication qualifies for a limited exception for communications about currently prescribe drugs or biologics where the payment received is reasonable in amount.

Continue Reading

HITECH Update #4: HHS Relaxes HIPAA Requirements for Research Authorizations

This post is part of our series on key aspects of the final HITECH omnibus rule issued by the U.S. Department of Health and Human Services (HHS) on January 17, 2013 (available here), and scheduled to be published in the Federal Register on January 25.  Previous posts are available here.  The regulations are effective March 26, 2013, but covered entities and business associates have until September 23, 2013, to comply with most new requirements. 

The final HITECH omnibus rule contains major changes to the HIPAA requirements for research authorizations.  Specifically, as described below, HHS has loosened the current restrictions on “compound authorizations” for research purposes, and is now interpreting the HIPAA Privacy Rule to allow authorizations for future research.  These changes could have a tremendous impact on the manner in which  informed consent for clinical trials is documented in the United States and on the availability of clinical trial data for future research.

Compound Authorizations.  The HIPAA Privacy Rule generally prohibits “compound authorizations,” which are authorizations that are combined with any other legal permission.  An exception allows the combining of an authorization for a research study with written permission for the same study, usually found in an informed consent form.  But under the current rules, this exception is not available if one authorization conditions treatment, payment, enrollment in a health plan, or eligibility for benefits on the individual providing an authorization (conditioned authorization) and the other authorization does not contain such conditions (unconditioned authorization).  This prevents a covered entity from, for example, using a single authorization for a research study that covers both treatment as part of a clinical study and tissue banking of specimens for future research.  Many groups have informed HHS that this lack of integration is inconsistent with the Common Rule (45 C.F.R. Part 46) and creates unnecessary documentation burdens.

Continue Reading

HITECH Update #3: HHS Revises Breach Notification Rule

This post is part of our series on key aspects of the final HITECH omnibus rule issued by the U.S. Department of Health and Human Services (HHS) on January 17, 2013 (available here), and scheduled to be published in the Federal Register on January 25.  Previous posts are available here.  The regulations are effective March 26, 2013, but covered entities and business associates have until September 23, 2013, to comply with most new requirements. 

The HITECH omnibus rule establishes a new standard for determining whether an unauthorized use or disclosure of unsecured protected health information (“PHI”) is a “breach” requiring notification.   Under the current Breach Notification Rule, covered entities are required to notify individuals of a breach involving their unsecured PHI, and business associates have a corresponding obligation to notify covered entities. The current rule states that an unauthorized use or disclosure of PHI is a “breach” if it poses a significant risk of financial, reputational, or other harm to the individuals affected.  

The omnibus rule replaces the “risk of harm” test with a default presumption that any acquisition, access, use, or disclosure of PHI in a manner not permitted by the HIPAA Privacy Rule is a breach unless the covered entity or business associate “demonstrates that there is a low probability that the [PHI] has been compromised based on a risk assessment.”  HHS stated that the omnibus rule establishes a presumption that uses or disclosures of PHI in violation of the Privacy Rule are “breaches” because HHS believes that many covered entities and business associates have construed the existing “risk of harm” standard as setting a higher bar than HHS intended.  Covered entities and business associates now have the burden of proving that there is a “low probability” that PHI has been compromised through a risk assessment that accounts for at least the following factors: 

  1.  The nature and extent of the PHI involved, including the types of identifiers and the likelihood of re-identification;
  2. The unauthorized person who used the PHI or to whom the disclosure was made;
  3. Whether the PHI was actually acquired or viewed; and
  4. The extent to which the risk to the PHI has been mitigated.

All of these factors must be considered in combination.  If a covered entity or business associate determines that an unauthorized use or disclosure of PHI is not a breach, it will need to maintain documentation sufficient to overcome the presumption that PHI was compromised.  HHS suggests that these risk assessments allow for a more “objective” evaluation than the current “risk of harm” standard, and plans to provide further guidance on risk assessments that addresses “frequently occurring scenarios.”

Continue Reading

HITECH Update #2: HHS Finalizes Privacy Rules to Protect Genetic Information

This post is part of our series on key aspects of the final HITECH omnibus rule issued by the U.S. Department of Health and Human Services (HHS) on January 17, 2013 (available here), and scheduled to be published in the Federal Register on January 25.  Previous posts are available here.  The regulations are effective March 26, 2013, but covered entities and business associates have until September 23, 2013, to comply with most new requirements. 

In addition to finalizing the HIPAA regulations under HITECH, the omnibus rule finalized modifications to the HIPAA Privacy rule required by the Genetic Information Non-Discrimination Act (GINA).  GINA prohibits discrimination in employment and health insurance coverage based on a person’s genetic information.  Specifically, GINA prohibits health plans from using the genetic information of an individual, for example that he or she is predisposed to develop a certain genetic disorder or carries a specific genetic mutation, for underwriting purposes.

GINA directed HHS to make modifications to the HIPAA Privacy Rule.  In October 2009, HHS promulgated proposed rules to:

  • Clarify that genetic information is health information for purposes of PHI;
  • Prohibit health plans from using or disclosing PHI containing genetic information for underwriting purposes;
  • Revise the provisions related to the Notice of Privacy Practices for health plans that perform underwriting; and
  • Make technical corrections to update the definition of “health plan.”

The structure of the final rules issued by HHS track these proposed rules, while making some modifications to the details of the individual proposals.  We discuss each of the major aspects of the proposed rule below.

Continue Reading

HHS Issues Long-Awaited Final HITECH Regulations

By Anna Kraus and Rachel Grunberger

The U.S. Department of Health and Human Services has issued its long-awaited final omnibus rule modifying the privacy, security, enforcement, and breach notification regulations under the Health Insurance Portability and Accountability Act of 1996 (HIPAA).  The rule is based on statutory changes under the Health Information Technology for Economic and Clinical Health (HITECH) Act and the Genetic Information Nondiscrimination Act of 2008 (GINA). 

The omnibus rule is comprised of the following four rules:

  1. Final modifications to the HIPAA regulations mandated by the HITECH Act, and certain other modifications to improve the HIPAA rules;
  2. Final rule adopting changes to the HIPAA Enforcement Rule;
  3. Final rule on Breach Notification for Unsecured Protected Health Information under the HITECH Act, which, according to HHS, replaces the current rule’s “risk of harm” threshold with a more objective standard; and
  4. Final rule modifying the HIPAA Privacy Rule as required by GINA.

This post is the first in a series that we will publish about key aspects of the final rule, including modifications to the HIPAA requirements for research, marketing, breach notification, business associates, and other issues.  Stay tuned for more details…

HHS Issues Message to Nation's Health Care Providers About HIPAA and Threats to Health and Safety

Following the release of the President’s plan to reduce gun violence, the Office for Civil Rights within the Department of Health and Human Services (HHS) issued a “Message to Our Nation’s Health Care Providers” regarding HIPAA and reporting threats of violence. 

In the letter, which was prompted by the recent mass shootings in Newtown, Connecticut, and Aurora, Colorado, HHS states that it wants to ensure that health care providers are aware that the HIPAA Privacy Rule does not prevent them from disclosing necessary information about a patient to law enforcement, family members of the patient, or other persons, when the health care provider believes the patient “presents a serious danger to himself or other people.”

Continue Reading

President's Gun Plan Addresses HIPAA Concerns, Clarifications

By Rachel Grunberger and Anna Kraus

Two measures in President Obama’s plan to reduce gun violence, released yesterday, seek to address privacy concerns related to the Health Insurance Portability and Accountability Act of 1996 (HIPAA). 

Mental Health Records and Background Checks.  The first measure, which is part of a set of recommendations to strengthen the National Instant Criminal Background Check System (NICS), is to address “unnecessary legal barriers that prevent states from reporting information [to NICS] about those prohibited from having guns.”  The President’s plan references a July 2012 Government Accountability Office (GAO) report on gun control, which found that although the number of mental health records available to the NICS has increased, there were still 17 states that  have made fewer than 10 mental health records available to the system.  One reason for this, according to the GAO, may be concerns under HIPAA.  The HIPAA Privacy Rule allows covered entities to use or disclose protected health information without the individual’s authorization under certain specified circumstances, such as when required by law.  A few state officials reported to GAO that the “absence of explicit state statutory authority to share mental health records was an impediment to making such records available to NICS.”

To address this issue, the President’s plan states that the “Administration will begin the regulatory process to remove any needless barriers, starting by gathering information about the scope or extent of the problem.”  (Interestingly, the GAO report states that the Department of Justice asked the Department of Health and Human Services to address this problem by amending the Privacy Rule to specifically allow disclosure of mental health records for NICS reporting purposes; however, as of the date of the report, HHS had not yet decided whether to pursue an amendment.)

Continue Reading

EDPS Suggests Amendments to the Commission Proposal for a new Regulation on Clinical Trials on Medicinal Products for Human Use

On 19 December 2012, the European Data Protection Supervisor (EDPS) and the Assistant Supervisor, M. Giovanni Buttarelli, published a new Opinion that sets out their views on the Commission proposal for a new Regulation on Clinical Trials on Medicinal Products for Human Use (the Regulation).  The Commission proposal, released in July 2012, touches on a variety of data protection issues, ranging from the legal basis that clinical research organisations (CROs) must rely on when processing sensitive health data gathered in clinical trials to the establishment of a centralized database at the European Medicines Agency (EMA) that is intended to store records of clinical investigators and adverse event reports from across Europe.

In general, the EDPS appears to have welcomed the Commission’s approach;  apparently, the Commission draft was altered to adapt to early informal EDPS criticisms, and so already contains provisions that are relatively sensitive to data privacy concerns.  Perhaps surprisingly, the EDPS also refrains from commenting extensively on the Regulation’s approach to the issue of how clinical trial participants may provide informed consent to their participation in the trial.  However, the EDPS nevertheless does make a number of suggestions about how the draft Regulation should be further modified.  We discuss the particular suggestions after the jump.

Continue Reading

HHS Announces First Settlement for HIPAA Breach Involving Less than 500 Patients

On January 2, HHS announced that it had entered into a HIPAA breach settlement with the Hospice of North Idaho (HONI) in what it reported as the first such settlement involving a breach of PHI affecting fewer than 500 individuals.  Under the resolution agreement, HONI agreed to pay HHS $50,000 and enter into a corrective action plan requiring HONI to report to HHS any time it determines that a workforce member has failed to comply with its Privacy and Security policies.

The investigation and settlement arose out of a breach notification report submitted by HONI, as required by the HIPAA breach notification rule.  HONI reported the theft of a laptop computer, which contained PHI of 441 patients.  During the subsequent investigation, HHS determined that HONI was not in compliance with two different requirements of the HIPAA security rule: (1) it had not conducted a risk analysis to safeguard ePHI, and (2) it did not have in place policies or procedures to address mobile device security.

HIPAA’s breach notification rules have different requirements for breaches affecting fewer than 500 individuals.  For these smaller breaches, a covered entity need only notify the Secretary on an annual basis and no later than 60 days after the end of the calendar year during which the breach occurred.  However, this settlement should put all covered entities on notice that even small-scale breaches can result in significant liability under HIPAA.

HHS used the announcement of the settlement to remind interested individuals of its new educational initiative on mobile devices, launched by the Office of Civil Rights and the HHS Office of the National Coordinator for Health Information Technology(ONC).  This new initiative instructs health care providers and other health care professionals on best practices to protect patient information when using mobile devices such as laptops, tablets, and smartphones.  The initiative also includes educational materials that providers can use to spread awareness among their organizations of the importance of securing mobile data.

HHS Releases Guidance on HIPAA De-Identification Standard

By Rachel Grunberger and Anna Kraus

On Monday, the U.S. Department of Health and Human Services (HHS) released guidance on methods for de-identification of protected health information (PHI) in accordance with the Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule.  The guidance, which was required under Section 13424(c) of the Health Information Technology for Economic and Clinical Health (HITECH) Act, answers questions about the two methods that can be used to satisfy the HIPAA de-identification standard in  45 C.F.R. § 164.514.  It also incorporates input from stakeholders that HHS received at a workshop held in March 2010.

As summarized in the figure below, the two methods by which health information can be designated as de-identified under HIPAA are (1) the “expert determination” method and (2) the “safe harbor” method.

de-identification chart 1.pngSource: HHS Guidance Regarding Methods for De-identification of PHI in Accordance with the HIPAA Privacy Rule

Continue Reading

Telemarketing Recap: Recent Key Developments at the FCC, FTC and in the Courts

A number of key developments affecting telemarketing emerged over the past week:

1.  The distinction between informational and telemarketing calls was further defined.  The 9th Circuit held that calls intended to impart information about a customer rewards program could be construed as “dual purpose” calls subject to federal and state telemarketing restrictions.  See Chesbro v. Best Buy Co., Inc.

2.  Effective dates were announced for the new requirements on autodialed and prerecorded calls that were adopted by the FCC in February 2012. 

  • Effective immediately:  all prerecorded “heath care” messages subject to HIPAA transmitted to residential lines are exempt from the FCC’s consent, identification, time-of-day, opt-out, and call abandonment requirements.
  • Effective November 15, 2012:  the FCC’s three percent call abandonment rate must be calculated on a 30-day basis for every telemarketing calling campaign.  (It is possible that the FCC will consider delaying this effective date to January 14, 2013, to align it with the interactive opt-out requirement discussed below.)
  • Effective January 14, 2013:  all prerecorded telemarketing calls must include an automated, interactive opt-out mechanism throughout the duration of the call, as well as a toll-free telephone number that can be contacted to opt out when a prerecorded telemarketing message is left on voicemail or an answering machine. 
  • Effective October 16, 2013:  prior express written consent is required to transmit prerecorded or autodialed telemarketing calls to wireless numbers, and the established business relationship exception no longer applies to prerecorded telemarketing calls to residential lines.

Continue Reading

HHS Announces $1.5 Million HIPAA Settlement with Massachusetts Provider

On September 17, the Department of Health and Human Services (HHS) announced a settlement with Massachusetts Eye and Ear Infirmary and Massachusetts Eye and Ear Associates, Inc. (collectively, MEEI) for alleged violations of the HIPAA Security Rule.  Under the Resolution Agreement, MEEI agreed to pay $1.5 million to HHS and take corrective action to improve its policies and procedures to ensure compliance with HIPAA.

Continue Reading

Older Posts